Endogenous opiates and behavior: 2006

RJ Bodnar - Peptides, 2007 - Elsevier
This paper is the 29th consecutive installment of the annual review of research concerning
the endogenous opioid system, now spanning 30 years of research. It summarizes papers …

Neuropathic pain: models and mechanisms

JM Boyce-Rustay, MF Jarvis - Current pharmaceutical design, 2009 - ingentaconnect.com
Advances in the characterization of pain signaling in recent years indicate that distinct
neurophysiological and neurochemical mechanisms contribute to pain arising from injury to …

Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood–spinal cord barrier after spinal cord injury

JY Lee, HS Kim, HY Choi, TH Oh, TY Yune - Brain, 2012 - academic.oup.com
After spinal cord injury, the disruption of blood–spinal cord barrier by activation of matrix
metalloprotease is a critical event leading to infiltration of blood cells, inflammatory …

Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics

OI Barygin, EI Nagaeva, DB Tikhonov, DA Belinskaya… - Brain research, 2017 - Elsevier
It is known that some antidepressants and antipsychotics directly inhibit NMDA-type
ionotropic glutamate receptors. In this study we systematically studied action of seven drugs …

Fluoxetine inhibits transient global ischemia-induced hippocampal neuronal death and memory impairment by preventing blood–brain barrier disruption

JY Lee, HE Lee, SR Kang, HY Choi, JH Ryu… - Neuropharmacology, 2014 - Elsevier
Ischemia induces blood–brain barrier (BBB) disruption by matrix metalloproteases (MMPs)
activation, leading to neuronal cell death. Here, we show that fluoxetine inhibits apoptotic …

A pyrazole-containing selenium compound modulates neuroendocrine, oxidative stress, and behavioral responses to acute restraint stress in mice

PT Birmann, M Domingues, AM Casaril… - Behavioural Brain …, 2021 - Elsevier
The contribution of oxidative stress has been described in numerous studies as one of the
main pathways involved in the pathophysiology of anxiety and its comorbidities, such as …

Receptor targets for antidepressant therapy in bipolar disorder: an overview

KN Fountoulakis, JR Kelsoe, H Akiskal - Journal of affective disorders, 2012 - Elsevier
The treatment of bipolar depression is one of the most challenging issues in contemporary
psychiatry. Currently only quetiapine and the olanzapine–fluoxetine combination are …

Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic …

YY Liu, D Yin, L Chen, WM Qu, CR Chen… - …, 2014 - Springer
Rationale An effective and safe treatment of insomnia in patients with neuropathic pain
remains an unmet need. Melatonin and its analogs have been shown to have both …

Clavulanic acid attenuating effect on the diabetic neuropathic pain in rats

M Kolahdouz, F Jafari, F Falanji, S Nazemi… - Neurochemical …, 2021 - Springer
Diabetic neuropathy is one of the most common complications of diabetes mellitus. Excess
glutamate release and oxidative stress are hypothesized to be involved in the …

[HTML][HTML] Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with …

P Sikka, S Kaushik, G Kumar, S Kapoor… - Journal of Pharmacy …, 2011 - journals.lww.com
Objective: to study the probable site of antinociceptive action of SSRI (fluoxetine,
escitalopram) and atypical antidepressants (mirtazapine, venlafaxine) and their interaction …